Cite
HARVARD Citation
Muddassir, M. et al. (2021). Bromodomain and BET family proteins as epigenetic targets in cancer therapy: their degradation, present drugs, and possible PROTACs. RSC advances. 11 (2), pp. 612-636. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Muddassir, M. et al. (2021). Bromodomain and BET family proteins as epigenetic targets in cancer therapy: their degradation, present drugs, and possible PROTACs. RSC advances. 11 (2), pp. 612-636. [Online].